PY 2/27/26 PY 2/27/26 Ab Initio Building Australia’s Next Generation Pharmaceutical Engine Read More PY 2/16/26 PY 2/16/26 Ab Initio Pharma to Support Advancement of NBX-200 Following Positive Phase 1 Results Read More PY 2/2/26 PY 2/2/26 Ab Initio to Host Joint Workshop on the Future of OINDP Drug Delivery in Sydney this February Read More PY 12/1/25 PY 12/1/25 Catch up with the Ab Initio Pharma team at DDL 2025 Read More PY 7/24/25 PY 7/24/25 Ab Initio Leads Oral Formulation of World-First Radiation Protectant Read More PY 7/16/25 PY 7/16/25 Strength in Science. Powered by People. Read More PY 7/8/25 PY 7/8/25 Ab Initio Supports Woolcock Institute Clinical Trial with Inhaled Therapy Manufacture and CRO Services Read More PY 6/12/25 PY 6/12/25 Ab Initio Pharma Proudly Sponsors PDC 2025! Read More PY 6/7/25 PY 6/7/25 Ab Initio Pharma Champions Innovation at NSW Drug Discovery Forum 2025 Read More PY 5/27/25 PY 5/27/25 Ab Initio Pharma is proud to once again sponsor the NSW Drug Discovery Forum 2025! Read More PY 5/21/25 PY 5/21/25 Explore GMP Excellence and Clinical Innovation with Ab Initio at ARCS 2025 Read More PY 5/20/25 PY 5/20/25 Leading the Way in Inhalation Science: Daniela Traini to Keynote at SMI London 2025 Read More PY 5/6/25 PY 5/6/25 Breathing Innovation: Ab Initio Pharma at RDD Europe 2025 Read More PY 12/19/24 PY 12/19/24 Season’s Greetings from the Ab Initio Pharma Team Read More PY 12/6/24 PY 12/6/24 Did You Know Ab Initio Leads the Way in Developing Inhaled and Nasal Biologics?: Meet with our CSO, YY at DDL 2024 Read More PY 12/1/24 PY 12/1/24 Join Ab Initio Pharma at DDL 2024: Shaping the Future of Inhaled Therapies Read More PY 11/27/24 PY 11/27/24 Ab Initio Featured on BioBeacon Read More PY 11/24/24 PY 11/24/24 Ab Initio Pharma Innovates at BioTech in NSW: Meet Our Team on December 6th in Sydney Read More PY 10/31/24 PY 10/31/24 Ab Initio Pharma Celebrates the Success of the Inaugural NSW Drug Discovery Conference Read More PY 10/11/24 PY 10/11/24 Book a time to meet with the team at AusBio 2024 Read More Older Posts
PY 2/16/26 PY 2/16/26 Ab Initio Pharma to Support Advancement of NBX-200 Following Positive Phase 1 Results Read More
PY 2/2/26 PY 2/2/26 Ab Initio to Host Joint Workshop on the Future of OINDP Drug Delivery in Sydney this February Read More
PY 7/8/25 PY 7/8/25 Ab Initio Supports Woolcock Institute Clinical Trial with Inhaled Therapy Manufacture and CRO Services Read More
PY 5/27/25 PY 5/27/25 Ab Initio Pharma is proud to once again sponsor the NSW Drug Discovery Forum 2025! Read More
PY 5/21/25 PY 5/21/25 Explore GMP Excellence and Clinical Innovation with Ab Initio at ARCS 2025 Read More
PY 5/20/25 PY 5/20/25 Leading the Way in Inhalation Science: Daniela Traini to Keynote at SMI London 2025 Read More
PY 12/6/24 PY 12/6/24 Did You Know Ab Initio Leads the Way in Developing Inhaled and Nasal Biologics?: Meet with our CSO, YY at DDL 2024 Read More
PY 12/1/24 PY 12/1/24 Join Ab Initio Pharma at DDL 2024: Shaping the Future of Inhaled Therapies Read More
PY 11/24/24 PY 11/24/24 Ab Initio Pharma Innovates at BioTech in NSW: Meet Our Team on December 6th in Sydney Read More
PY 10/31/24 PY 10/31/24 Ab Initio Pharma Celebrates the Success of the Inaugural NSW Drug Discovery Conference Read More
